PPARs in atherosclerosis: The spatial and temporal features from mechanism to druggable targets
Yi Zheng(Beijing University of Chinese Medicine), Lingru Li(Beijing University of Chinese Medicine), Mingyan Shao(Beijing University of Chinese Medicine), Yanfei Zheng(Beijing University of Chinese Medicine), Wenlong Sun(Shandong University of Technology), Si Qin(Hunan Agricultural University), Yong Wang(Beijing University of Chinese Medicine), Linghui Zhu(Chinese Academy of Medical Sciences & Peking Union Medical College), Qi Wang(Beijing University of Chinese Medicine), Yuanyuan Guan(Harbin Medical University), Ziwei Sun(Beijing University of Chinese Medicine)
Cited by 33
Related Papers
Myricetin supplementation decreases hepatic lipid synthesis and inflammation by modulating gut microbiota
|Cell Reports|2021|120
Lymphatic-localized Treg-mregDC crosstalk limits antigen trafficking and restrains anti-tumor immunity
|Cancer Cell|2024|115
Phlegm-Dampness Constitution: Genomics, Susceptibility, Adjustment and Treatment with Traditional Chinese Medicine
|The American Journal of Chinese Medicine|2013|108
Traditional Chinese Medicine and Constitutional Medicine in China, Japan and Korea: A Comparative Study
|The American Journal of Chinese Medicine|2017|102